EXEL
insider transactionsEXELIXIS, INC. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-688.6K
0 buy · 688.6K sell
Net value · 365d
-$31.2M
$0 in · $31.2M out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
23
0 buy · 688.6K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Sell·S
Director · 10b5-1
$198.4K
3.9K sh · $50.55
Own -1%
-
Sell·S
Director · 10b5-1
$492.0K
9.8K sh · $50.14
Own -38%
-
Grant·A
Director
$0
8.4K sh
Own +1%
-
Grant·A
Director
$0
8.4K sh
Own +20%
-
Grant·A
Director
$0
8.4K sh
Own +48%
-
Grant·A
Director
$0
8.4K sh
Own +41%
-
Grant·A
Director
$0
8.4K sh
Own +8%
-
Grant·A
Director
$0
8.4K sh
Own +40%
-
Grant·A
Director
$0
8.4K sh
Own +3%
-
Grant·A
Director
$0
8.4K sh
Own +7%
-
Grant·A
Director
$0
8.4K sh
Own +48%
-
Sell·S
EVP, Research and Development
$2.2M
43.5K sh · $50.35
Own -7%
-
Sell·S
EVP, Commercial
$1.6M
32.1K sh · $49.81
Own -8%
-
Other·G
President and CEO
$0
124.0K sh
Own -8%
-
Sell·S
EVP and CFO
$1.7M
34.9K sh · $50.00
Own -4%
-
Sell·S
SVP and General Counsel · 10b5-1
$332.6K
6.6K sh · $50.21
Own -6%
-
Other·F
President and CEO
$6.6M
128.5K sh · $51.10
Own -8%
-
Other·F
EVP and CFO
$2.1M
40.9K sh · $51.10
Own -4%
-
Other·F
EVP, Commercial
$1.7M
33.3K sh · $51.10
Own -8%
-
Other·F
SVP and General Counsel · 10b5-1
$327.6K
6.4K sh · $51.10
Own -5%
-
Other·F
EVP, Research and Development
$1.6M
30.6K sh · $51.10
Own -5%
-
Exercise·M
Director
$0
20.6K sh
Own New
-
Sell·S
Director
$949.2K
20.6K sh · $46.00
Own -17%
-
Exercise·M
Director
$407.9K
20.6K sh · $19.77
Own +20%
-
Sell·S
Director
$2.7M
60.0K sh · $45.71
Own -34%
-
Exercise·M
Director
$0
3.9K sh
Own +43%
-
Sell·S
Director
$373.6K
7.7K sh · $48.45
Own -31%
-
Exercise·M
Director
$89.6K
3.9K sh · $23.24
Own +18%
-
Other·G
President and CEO
$0
109.7K sh
Own -6%
-
Grant·A
Director
$0
975 sh
Own +6%
-
Grant·A
EVP and CFO
$0
52.0K sh
Own +5%
-
Grant·A
SVP and General Counsel
$0
23.1K sh
Own +24%
-
Grant·A
EVP, Commercial
$0
40.5K sh
Own +11%
-
Grant·A
President and CEO
$0
160.4K sh
Own +11%
-
Grant·A
EVP, Research and Development
$0
52.0K sh
Own +8%
-
Other·G
President and CEO
$0
100.3K sh
Own -5%
-
Sell·S
EVP, Research and Development
$2.1M
47.9K sh · $44.50
Own -7%
-
Sell·S
EVP, Research and Development
$1.3M
29.9K sh · $44.35
Own -4%
-
Other·G
President and CEO
$0
125.1K sh
Own -8%
-
Sell·S
SVP and General Counsel · 10b5-1
$821.6K
18.7K sh · $44.01
Own -16%
-
Exercise·M
Director
$0
20.0K sh
Own New
-
Exercise·M
Director
$0
44.1K sh
Own New
-
Sell·S
Director
$887.3K
20.0K sh · $44.30
Own -49%
-
Exercise·M
Director
$434.5K
20.0K sh · $21.69
Own +97%
-
Sell·S
Director
$2.0M
44.1K sh · $44.50
Own -68%
-
Exercise·M
Director
$854.8K
44.1K sh · $19.39
Own +214%
-
Exercise·M
Director · 10b5-1
$0
20.6K sh
Own New
-
Sell·S
Director · 10b5-1
$4.4M
99.6K sh · $44.01
Own -26%
-
Exercise·M
Director · 10b5-1
$407.9K
20.6K sh · $19.77
Own +6%
-
Sell·S
EVP and CFO
$1.3M
30.6K sh · $43.67
Own -3%
-
Sell·S
EVP, Commercial
$2.8M
64.8K sh · $43.50
Own -15%
-
Sell·S
EVP, Commercial
$133.1K
3.0K sh · $43.84
Own -1%
-
Other·G
President and CEO
$0
250.7K sh
Own -14%
-
Exercise·M
Director
$0
42.4K sh
Own New
-
Sell·S
Director
$1.8M
42.4K sh · $43.33
Own -67%
-
Exercise·M
Director
$771.7K
42.4K sh · $18.19
Own +206%
-
Other·F
EVP and CFO
$1.6M
35.9K sh · $43.92
Own -3%
-
Other·F
EVP, Commercial
$1.4M
31.5K sh · $43.92
Own -7%
-
Other·F
President and CEO
$5.3M
120.4K sh · $43.92
Own -6%
-
Other·F
SVP and General Counsel · 10b5-1
$238.5K
5.4K sh · $43.92
Own -5%
-
Other·F
EVP, Research and Development
$558.7K
12.7K sh · $43.92
Own -2%
-
Other·F
EVP, Research and Development
$1.2M
26.5K sh · $43.92
Own -4%
-
Sell·S
EVP and CFO
$1.5M
34.3K sh · $43.00
Own -3%
-
Exercise·M
President and CEO
$0
494.7K sh
Own New
-
Other·F
President and CEO
$16.2M
369.6K sh · $43.92
Own -16%
-
Exercise·M
President and CEO
$10.5M
494.7K sh · $21.31
Own +27%
-
Sell·S
Director · 10b5-1
$168.9K
3.9K sh · $43.79
Own -18%
-
Exercise·M
Director
$0
9.1K sh
Own +300%
-
Sell·S
Director
$929.0K
21.2K sh · $43.90
Own -50%
-
Sell·S
Director
$396.3K
9.1K sh · $43.61
Own -18%
-
Exercise·M
Director
$175.2K
9.1K sh · $19.28
Own +21%
-
Grant·A
Director
$0
12.4K sh
Own +128%
-
Other·F
President and CEO
$6.3M
139.5K sh · $45.23
Own -7%
-
Grant·A
President and CEO
$0
548.1K sh
Own +39%
-
Other·F
EVP, Commercial
$1.5M
32.3K sh · $45.23
Own -6%
-
Grant·A
EVP, Commercial
$0
139.5K sh
Own +37%
-
Other·F
EVP and CFO
$1.8M
40.5K sh · $45.23
Own -4%
-
Grant·A
EVP and CFO
$0
149.5K sh
Own +15%
-
Other·F
EVP, Research and Development
$1.2M
27.3K sh · $45.23
Own -4%
-
Grant·A
EVP, Research and Development
$0
119.6K sh
Own +19%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 1, 2026 | Jack L Wyszomierski 10b5-1 | Sell S | 3.9K | $198.4K |
| Jun 1, 2026 | Sue Gail Eckhardt 10b5-1 | Sell S | 9.8K | $492.0K |
| May 27, 2026 | Stelios Papadopoulos | Grant A | 8.4K | $0 |
| May 27, 2026 | Tomas J. Heyman | Grant A | 8.4K | $0 |
| May 27, 2026 | Sue Gail Eckhardt | Grant A | 8.4K | $0 |
| May 27, 2026 | Julie Smith | Grant A | 8.4K | $0 |
| May 27, 2026 | Maria C Freire | Grant A | 8.4K | $0 |
| May 27, 2026 | Bob Oliver | Grant A | 8.4K | $0 |
| May 27, 2026 | Jack L Wyszomierski | Grant A | 8.4K | $0 |
| May 27, 2026 | George Poste | Grant A | 8.4K | $0 |
| May 27, 2026 | Mary C Beckerle | Grant A | 8.4K | $0 |
| May 26, 2026 | Dana Aftab | Sell S | 43.5K | $2.2M |
| May 20, 2026 | Patrick J. Haley | Sell S | 32.1K | $1.6M |
| May 18, 2026 | Michael Morrissey KEY | Other G | 124.0K | $0 |
| May 18, 2026 | Christopher J. Senner KEY | Sell S | 34.9K | $1.7M |
| May 18, 2026 | Brenda Hefti 10b5-1 | Sell S | 6.6K | $332.6K |
| May 15, 2026 | Michael Morrissey KEY | Other F | 128.5K | $6.6M |
| May 15, 2026 | Christopher J. Senner KEY | Other F | 40.9K | $2.1M |
| May 15, 2026 | Patrick J. Haley | Other F | 33.3K | $1.7M |
| May 15, 2026 | Brenda Hefti 10b5-1 | Other F | 6.4K | $327.6K |
| May 15, 2026 | Dana Aftab | Other F | 30.6K | $1.6M |
| May 7, 2026 | Maria C Freire | Exercise M | 20.6K | $0 |
| May 7, 2026 | Maria C Freire | Sell S | 20.6K | $949.2K |
| May 7, 2026 | Maria C Freire | Exercise M | 20.6K | $407.9K |
| May 7, 2026 | George Poste | Sell S | 60.0K | $2.7M |
| May 7, 2026 | Mary C Beckerle | Exercise M | 3.9K | $0 |
| May 7, 2026 | Mary C Beckerle | Sell S | 7.7K | $373.6K |
| May 7, 2026 | Mary C Beckerle | Exercise M | 3.9K | $89.6K |
| May 6, 2026 | Michael Morrissey KEY | Other G | 109.7K | $0 |
| Apr 23, 2026 | Mary C Beckerle | Grant A | 975 | $0 |
| Feb 26, 2026 | Christopher J. Senner KEY | Grant A | 52.0K | $0 |
| Feb 26, 2026 | Brenda Hefti | Grant A | 23.1K | $0 |
| Feb 26, 2026 | Patrick J. Haley | Grant A | 40.5K | $0 |
| Feb 26, 2026 | Michael Morrissey KEY | Grant A | 160.4K | $0 |
| Feb 26, 2026 | Dana Aftab | Grant A | 52.0K | $0 |
| Feb 24, 2026 | Michael Morrissey KEY | Other G | 100.3K | $0 |
| Feb 24, 2026 | Dana Aftab | Sell S | 47.9K | $2.1M |
| Feb 19, 2026 | Dana Aftab | Sell S | 29.9K | $1.3M |
| Feb 18, 2026 | Michael Morrissey KEY | Other G | 125.1K | $0 |
| Feb 18, 2026 | Brenda Hefti 10b5-1 | Sell S | 18.7K | $821.6K |
| Feb 18, 2026 | Julie Smith | Exercise M | 20.0K | $0 |
| Feb 18, 2026 | Julie Smith | Exercise M | 44.1K | $0 |
| Feb 18, 2026 | Julie Smith | Sell S | 20.0K | $887.3K |
| Feb 18, 2026 | Julie Smith | Exercise M | 20.0K | $434.5K |
| Feb 18, 2026 | Julie Smith | Sell S | 44.1K | $2.0M |
| Feb 18, 2026 | Julie Smith | Exercise M | 44.1K | $854.8K |
| Feb 18, 2026 | Jack L Wyszomierski 10b5-1 | Exercise M | 20.6K | $0 |
| Feb 18, 2026 | Jack L Wyszomierski 10b5-1 | Sell S | 99.6K | $4.4M |
| Feb 18, 2026 | Jack L Wyszomierski 10b5-1 | Exercise M | 20.6K | $407.9K |
| Feb 17, 2026 | Christopher J. Senner KEY | Sell S | 30.6K | $1.3M |
| Feb 17, 2026 | Patrick J. Haley | Sell S | 64.8K | $2.8M |
| Feb 17, 2026 | Patrick J. Haley | Sell S | 3.0K | $133.1K |
| Feb 17, 2026 | Michael Morrissey KEY | Other G | 250.7K | $0 |
| Feb 17, 2026 | Julie Smith | Exercise M | 42.4K | $0 |
| Feb 17, 2026 | Julie Smith | Sell S | 42.4K | $1.8M |
| Feb 17, 2026 | Julie Smith | Exercise M | 42.4K | $771.7K |
| Feb 15, 2026 | Christopher J. Senner KEY | Other F | 35.9K | $1.6M |
| Feb 15, 2026 | Patrick J. Haley | Other F | 31.5K | $1.4M |
| Feb 15, 2026 | Michael Morrissey KEY | Other F | 120.4K | $5.3M |
| Feb 15, 2026 | Brenda Hefti 10b5-1 | Other F | 5.4K | $238.5K |
| Feb 15, 2026 | Dana Aftab | Other F | 12.7K | $558.7K |
| Feb 15, 2026 | Dana Aftab | Other F | 26.5K | $1.2M |
| Feb 13, 2026 | Christopher J. Senner KEY | Sell S | 34.3K | $1.5M |
| Feb 13, 2026 | Michael Morrissey KEY | Exercise M | 494.7K | $0 |
| Feb 13, 2026 | Michael Morrissey KEY | Other F | 369.6K | $16.2M |
| Feb 13, 2026 | Michael Morrissey KEY | Exercise M | 494.7K | $10.5M |
| Feb 13, 2026 | Sue Gail Eckhardt 10b5-1 | Sell S | 3.9K | $168.9K |
| Feb 13, 2026 | Bob Oliver | Exercise M | 9.1K | $0 |
| Feb 13, 2026 | Bob Oliver | Sell S | 21.2K | $929.0K |
| Feb 13, 2026 | Bob Oliver | Sell S | 9.1K | $396.3K |
| Feb 13, 2026 | Bob Oliver | Exercise M | 9.1K | $175.2K |
| Feb 12, 2026 | Mary C Beckerle | Grant A | 12.4K | $0 |
| Jan 15, 2026 | Michael Morrissey KEY | Other F | 139.5K | $6.3M |
| Jan 15, 2026 | Michael Morrissey KEY | Grant A | 548.1K | $0 |
| Jan 15, 2026 | Patrick J. Haley | Other F | 32.3K | $1.5M |
| Jan 15, 2026 | Patrick J. Haley | Grant A | 139.5K | $0 |
| Jan 15, 2026 | Christopher J. Senner KEY | Other F | 40.5K | $1.8M |
| Jan 15, 2026 | Christopher J. Senner KEY | Grant A | 149.5K | $0 |
| Jan 15, 2026 | Dana Aftab | Other F | 27.3K | $1.2M |
| Jan 15, 2026 | Dana Aftab | Grant A | 119.6K | $0 |
About EXEL insider trading
This page tracks insider transactions for EXELIXIS, INC. (EXEL) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.